A5013806987- Transplantation: Methods and Outcomes
- Cardiac Arrhythmias and Treatments
- Mechanical Circulatory Support Devices
- Viral Infections and Immunology Research
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Cardiac electrophysiology and arrhythmias
- Heart Rate Variability and Autonomic Control
- Renal Transplantation Outcomes and Treatments
- Health and Medical Education
- Organ Transplantation Techniques and Outcomes
- Potassium and Related Disorders
- Cardiovascular Issues in Pregnancy
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Disease and Adiposity
- Cardiac tumors and thrombi
- Blood Pressure and Hypertension Studies
- Heart rate and cardiovascular health
- Aortic Disease and Treatment Approaches
Hospital Universitario Reina Sofía
2013-2024
Andalusian Health Service
2011
Sociedad Española de Cardiología
2009
University of Córdoba
2003
Our objective was to evaluate the impact of asymptomatic acute cellular rejection (ACR) in left ventricular myocardial strain heart transplant (HT) recipients by means two-dimensional speckle tracking echocardiography (2DSTE).From September 1, 2009 December 15, 2010 a conventional and 2DSTE exam performed on all consecutive HT their first year posttransplantation within 3 hours surveillance endomyocardial biopsies, as well 14 healthy controls. The association echocardiographic variables with...
Abstract Background Anticoagulation in heart transplant (HT) recipients increases the risk of hemorrhagic complications, so correct reversal anticoagulation is needed. Dabigatran, a direct thrombin inhibitor, increasingly used for patients with non‐valvular atrial fibrillation (NVAF) whose effect can be reversed by idarucizumab. Aim To present nationwide experience using idarucizumab urgent dabigatran before HT. Methods Multicenter observational study 12 Spanish centers to analyze clinical...
A 62-year-old man with ischaemic cardiomyopathy complained of an increase basal dyspnoea. CRT-D (Medtronic InSync III Marquis, Minneapolis, MN, USA) was implanted 7 months ago. The leads were inserted without complication through the left subclavian vein and secured a …
The Index for Mortality Prediction After Cardiac Transplantation (IMPACT) score was derived and validated as a predictor of mortality after heart transplantation (HT). primary objective this work is to externally validate the IMPACT in contemporary Spanish cohort.Spanish Heart Transplant Registry data were used identify adult (>16 years) HT patients between January 2000 December 2015. Retransplantation, multiorgan whom at least one variables required calculate missing excluded from analysis...
Background Acute allograft rejection (AAR) is an important cause of morbi-mortality in heart transplant (HT) patients, particularly during the first year. Endomyocardial biopsy (EMB) "gold standard" to guide post- transplantation treatment. However, it associated with complications that can be potentially serious. Index microvascular resistance (IMR) a specific physiological parameter measure function. An increased IMR measured early after HT has been acute cellular (ACR), higher all-cause...